The compaction of DNA into chromatin provides an additional level of gene regulation in eukaryotes that may not be available to prokaryotes. When packaged as chromatin, most promoters are transcriptionally repressed, and transcription factors have reduced access to their binding sites. The glucocorticoid receptor (GR) is a ligand-activated transcription factor that regulates the activity of genes involved in many physiological processes. To regulate eukaryotic genes, the GR binds to target sites within promoter regions of genes assembled as chromatin. This interaction alters the nucleosomal architecture to allow binding of other transcription factors, and formation of the preinitiation complex. The mouse mammary tumor virus (MMTV) promoter has been used extensively as a model to explore the processes by which the GR remodels chromatin and activates transcription. Signi®cant progress has been made in our understanding of the mechanisms used by the GR to modify chromatin structure, and the limits placed on the GR by post-translational modi®cations of histones. We will describe recent developments in the processes used by the GR to activate transcription in vivo via chromatin remodeling complexes, histone H1 phosphorylation, and recruitment of diverse coactivators. Oncogene (2001) 20, 3039 ± 3046.
Introduction
Glucocorticoids mediate eukaryotic development, homeostasis, and response to stress through the glucocorticoid receptor (GR) (Karin, 1998) . The GR is a ligandactivated transcription factor, and one of the ®rst eukaryotic transcription factors to be identi®ed (Weinberger et al., 1985) . Since its discovery in the 1970s, the GR has provided a model for understanding signal transduction, and the mechanisms used by nuclear receptors and other sequence-speci®c transcription factors to regulate gene expression (Yamamoto, 1985) . The GR is the prototypical nuclear receptor, and is structurally similar to other nuclear receptors such as the progesterone receptor, androgen receptor, and mineralocorticoid receptor (Mangelsdorf et al., 1995) These four receptors regulate gene expression directly by binding to a hormone response element, or HRE, in the promoter regions of glucocorticoid-responsive genes. To mediate so many physiological processes, the GR must regulate diverse promoters in a variety of cell types. Depending on the cellular and promoter context, the GR exploits dierent mechanisms to activate transcription. One of these mechanisms is modi®cation of chromatin structure. (Archer et al., 1997) .
The basic structural element of chromatin is the nucleosome, which consists of approximately 146 bp of DNA wrapped around two molecules each of four core histones ± H2A, H2B, H3 and H4 (Fletcher and Hansen, 1996; Wole and Hayes, 1999) . This core histone octamer, along with the linker histone H1 between nucleosomes, allows for DNA compaction to form the chromosome. Although this structural arrangement facilitates DNA packaging, chromatin structure generally represents a barrier to transcription (Collingwood et al., 1999; Orphanides and Reinberg, 2000) . DNA packaged as chromatin resists nuclease attack, and inhibits binding of transcription factors to their recognition sequences (Gross and Garrard, 1988) . Molecular events that alter local chromatin structure are generally associated with increased nuclease sensitivity and access of transcription factors to their cognate sites. Compared to naked DNA, most transcription factors bind less eectively to nucleosomal DNA by several orders of magnitude (Collingwood et al., 1999) . However, few models exist where the chromatin structure of a particular promoter is known at a sucient resolution to accurately predict how a speci®c chromatin structure in¯uences gene activation. One such model which has been studied extensively for GR-activated transcription within chromatin is the Mouse Mammary Tumor Virus (MMTV) promoter (Archer et al., 1989; Hager and Archer, 1991) .
The MMTV-LTR fragment of retroviral DNA organizes into six positioned nucleosomes in a chromosomal or episomal context (Archer et al., 1997) . (Figure 1 ). Nucleosomes A and B contain the proximal promoter, and nuc-B contains four hormone response elements (HREs) that allow strong activation of the promoter by glucocorticoids. The proximal promoter also contains binding sites for nuclear factor 1 (NF1), octamer transcription factors (OTFs), and the TATA-binding protein (TBP). Glucocorticoid treat-ment renders the nuc-B region of MMTV hypersensitive to endonucleases. This hypersensitive or`remodeled' chromatin is characteristic of regions withiǹ active' chromatin and often signals factor binding sites. Prior to hormone treatment, the repressive chromatin structure of MMTV excludes NF1, OTF, and TBP binding (Archer et al., 1997) . Hormone treatment and subsequent GR binding to HREs induces a structural transition of nuc-B which allows NF1, OTF, and TBP to bind (Lee and Archer, 1994) . Histone H1 is lost, although the core histones are not (Bresnick et al., 1992) . This series of events allows formation of a preinitiation complex, and transcription proceeds. However, when MMTV promoter DNA is transiently introduced into tissue culture cells, the DNA fails to acquire the speci®c nucleosomal architecture described for the integrated promoter (Archer et al., 1992) . On this transient MMTV template, NF1 and OTF are constitutively bound to the promoter, and do not require the GR for binding (Lee and Archer, 1994) . These studies supported a bimodal activation model of the GR, in which ligandinduced GR binding induces chromatin remodeling and subsequent access of transcription factors to their binding sites (Archer et al., 1989 (Archer et al., , 1997 .
In this review we will examine new information from the last 3 years further connecting chromatin to GR mediated transcription. Speci®cally, we will discuss the accessory factors that the GR requires for transcription of MMTV, such as the Swi/Snf chromatin-remodeling complex. In addition, we will discuss the impact of histone H1 phosphorylation on MMTV transcription.
GR and chromatin-remodeling complexes
One critical set of enzymatic superstructures that overcomes the repressive nature of chromatin structure are the chromatin-remodeling complexes (CRCs). These 1 ± 2 MDa multisubunit complexes require ATP to disrupt chromatin and are conserved from yeast to humans (for review see Vignali et al., 2000) . There are three main families of CRCs, based on the ATPase subunit contained within the complex. These families are Swi/Snf, ISWI, and Mi-2. The Swi/Snf complex was originally identi®ed in Saccharomyces cerevisiae, and related complexes have been discovered in Drosophila and humans (Sudarsanam and Winston, 2000) . Swi/Snf is capable of several biochemical activities that provide its chromatin disrupting properties. On nucleosomal arrays in vitro, Swi/Snf increases sensitivity of DNA to deoxyribonuclease I and restriction endonucleases (Logie and Peterson, 1997; Owen-Hughes et al., 1996; Schnitzler et al., 1998) Other in vitro evidence suggests that Swi/Snf may slide nucleosomes in cis to other sites on the same stretch of DNA, or transfer histone octamers in trans to other DNA molecules (Lorch et al., 1999; Owen-Hughes et al., 1996; Whitehouse et al., 1999) . Swi/Snf complexes have also been shown to convert mononucleosomes to an alternate, stable state characterized by changes in micrococcal nuclease, deoxyribonuclease I, and restriction enzyme cleavage (Schnitzler et al., 1998) . In the same study, Swi/Snf also converted this altered nucleosome back to its original state. More recently, the Swi/Snf complex, as well as other ATP dependent chromatin remodeling complexes have been shown to possess the ability to generate superhelical torsion in vitro suggesting a possible mechanism to modify chromatin structure in vivo (Havas et al., 2000) .
In humans, two Swi/Snf-like multisubunit complexes have been puri®ed, known as BRG1 and BRM, based on the ATPase subunit for the complex (Wang et al., 1996a,b) . The ATPases BRG1 and BRM, which are more than 70% identical, are highly homologous to yeast Swi/Snf2, the ATPase in yeast Swi/Snf (Eisen et al., 1995) . BRG1 may be critical for cancer progression, since BRG1 is homozygously deleted or mutated in several human tumor cell lines (Wong et al., 2000) . In a number of additional cancer cell lines, BRG1 and BRM expression was completely absent, perhaps indicative of a possible tumor suppressor role for these molecules. BRG1 and BRM complexes have been found in numerous cell lines and a wide range of tissues. Other proteins, known as BRG1-associated factors or BAFs, are associated with these ATPase subunits. It has been suggested that the composition of the BRG1 or BRM complex may vary depending on cell type, each containing a dierent subset of BAFs with an ATPase subunit (Vignali et al., 2000) . Although most Swi/Snf complexes contain at least eight proteins, all Swi/Snf complexes contain a core set of components (Phelan et al., 1999) . This`minimum catalytic core' consisting of three proteins ± BRG1, INI1 (BAF47), and BAF155/BAF170 ± can remodel mononucleosomes and nucleosomal arrays in vitro (Phelan et al., 1999) . A human Swi/Snf-related complex, E-RC1, has been puri®ed from mouse erythroleukemia cells and contains BRG1, BAF170, BAF155, INI1 (BAF47), and BAF57 (Armstrong et al., 1998) . This complex disrupts nucleosomes on b-globin promoter sequences assembled in vitro. E-RC1 also appears to be speci®cally targeted by the transcription factor EKLF (Erythroid KruÈ ppel-like Factor) to the bglobin promoter, since the complex could not activate expression from a second reconstituted template activated by a dierent transcription factor (Kadam et al., 2000) . On this promoter, BRG1 and BAF155 were necessary and sucient for nucleosome disruption and transactivation by EKLF in vitro. These various BRG1/BAF-containing complexes (hereafter termed BRG1 complex') may be targeted by dierent transcription factors. For example, the BRG1-BAF155 complex does not interact or function with all transcription factors, but appears to bind selectively to speci®c proteins (Kadam et al., 2000) .
On the MMTV promoter, the GR requires the BRG1 complex for remodeling and activation of the promoter . (Figure 2). It had previously been shown that in T47D cells that express both the GR and progesterone receptor (PR), the PR activates transcription from a transiently transfected MMTV reporter, but not from an integrated template organized as chromatin . In addition, the activated PR bound to a Type II antiprogestin blocked glucocorticoid-induced activation of the promoter. The same PR-antiprogestin complex also inhibited chromatin remodeling by the GR . To further investigate how the PR inhibited GR activity. GR binding to the BRG1 complex was investigated. In the presence of ligand, the GR associated with the BRG1 and BAF155 subunits of this complex. This interaction could be eliminated by treatment with a Type II antiprogestin, which led to dissociation of the GR-BRG1 complex. Antiprogestin treatment also inhibited ligand-dependent chromatin remodeling and transcriptional activation. Overexpression of the BRG1 subunit eliminated the inhibition of glucocorticoid induction of MMTV by the antiprogestin, suggesting that the PR and GR compete for limiting amounts of BRG1. The chromatin-speci®c requirement for BRG1 was also demonstrated, since, unlike the stable MMTV promoter, transactivation of transiently introduced templates was unaected by antiprogestin treatment . This dierence between integrated and transient promoters suggests that templates lacking a phasednucleosomal arrangement may depend on GR association with other cofactors such as SRC1 and p300/CBP for transcriptional activity. Thus, recruitment of the BRG1 complex appears to be the primary regulatory event for MMTV transcriptional activation. These dierences between chromatin and transient templates have been supported by the creation of synthetic transcription factors linking a zinc-®nger binding domain to a VP16 transcriptional activation domain (Zhang et al., 2000) . These synthetic factors activate transiently introduced erythropoietin gene promoter reporter constructs, but only a subset activates the endogenous chromosomal locus. These results also point to the importance of considering chromatin structure when designing transcriptional targets as pharmaceutical agents.
This critical requirement for BRG1 recruitment to the MMTV promoter for glucocorticoid-mediated transcription is further supported by recent in vitro evidence. The GR has been shown in vitro to stimulate BRG1 chromatin remodeling using partially puri®ed complexes from either HeLa cells or from rat liver tissue (Ostlund Farrants et al., 1997) . On MMTV LTR DNA reconstituted into polynucleosome arrays with Drosophila embryo extracts, puri®ed GR required ATP and HeLa nuclear extract to induce chromatin remodeling (Fletcher et al., 2000) . Yeast Swi/Snf stimulated transcription via the N-terminal transactivation domain of the GR, tl, from assembled chromatin templates (Wallberg et al., 2000) . In the same report, BRM potentiated tl-dependent activation of a transiently introduced glucocorticoid-responsive promoter in human cervical carcinoma cells. Transfected BRM had previously been shown to protentiate transcriptional activation by the glucocorticoid receptor (GR) in a mouse cell line (Muchardt and Yaniv, 1993) . Figure 2 Glucocorticoid activation of the MMTV promoter requires the BRG1 complex. In the absence of hormone, nuc-B is closed and transcription factors such as NF1 and TBP cannot access their binding sites. In the presence of glucocorticoid, the GR targets the BRG1 complex to the proximal promoter, at least in part through the subunit, BAF250. The subsequent chromatin remodeling allows other factors such as NF1 to bind to the promoter. Once a preinitiation complex forms, transcription proceeds How does BRG1 enhance GR-mediated promoter activation? There is evidence that the GR recruits the BRG1 complex to promoters via protein ± protein interactions with BAF250, a subunit of the complex (Nie et al., 2000) . In T47D human breast cancer cells lacking BAF250, addition of this BAF enhanced GRmediated transcriptional activation of a transiently introduced promoter (Nie et al., 2000) . Mapping of BAF250 identi®ed the C-terminus as the region critical for GR-mediated transcription. BAF250 bound DNA, and interacted both in vitro and in vivo with the GR (Nie et al., 2000) . Taken together, these data support a model in which the GR targets the BRG1 complex to the promoter by interaction with the subunit, BAF250. Once escorted to the promoter, BRG1 induces chromatin remodeling, and transcription proceeds. The concept of the GR as a delivery vehicle represents a further evolution in our thinking on the mechanism(s) by which hormone dependent chromatin remodeling takes place. Initial studies in this system had demonstrated that while the GR was critical to initiate the cascade of chromatin remodeling events and capable of binding to an HRE on a nucleosome in vitro, it was not detected on the HRE in vivo. This led to a so-called`hit and run' or`cycling' mechanism of action where the GR, in contrast to NF1, would only transiently associate with the promoter (Archer et al., 1989) . Dramatic support for this model has recently come from cell biology experiments where the rapid association and disassociation of a GFP-tagged GR was seen in living cells at a MMTV-LTR array (McNally et al., 2000) .
GR and histone H1 phosphorylation
The MMTV promoter has also provided information on another type of chromatin-disrupting mechanism ± modi®cation of histones. Histones can be posttranslationally modi®ed in several ways, including acetylation, phosphorylation, ubiquitination, methylation and ADP-ribosylation (Cheung et al., 2000) . In addition to the core histones, linker histones such as H1 stabilize nucleosomes and facilitate the formation of higher order chromatin structures. Linker histones consist of a central globular domain¯anked by N-and C-terminal tails. These tails contain numerous basic residues, and bind both linker DNA and DNA within the nucleosome core (Wole and Hayes, 1999). Thus, modi®cations of linker histones would provide a mechanism to disrupt local and higher order chromatin structure, facilitating access of regulatory factors to promoter regions (Fletcher and Hansen, 1996) .
Evidence for the importance of histone H1 in transcriptional regulation is supported by several studies (Crane-Robinson, 1999) . In Tetrahymena strains lacking the globular domain of histone H1, a subset of genes are activated or repressed (Shen and Gorovsky, 1996) . During development in H1-de®cient Xenopus laevis, certain oocyte-speci®c 5S rRNA and mesodermal-speci®c genes are constitutively active (Bouvet et al., 1994; Steinback et al., 1997) . Phosphorylation of H1 regulates its eect on transcriptional activation, and occurs primarily on the basic N-and Cterminal tails (Wole and Hayes, 1999) . This phosphorylation weakens the interaction of the tails with the DNA backbone. Further evidence for the critical role of H1 phosphorylation in regulating transcription has recently been reported Mizzen et al., 1999) . CyP1 gene expression requires H1 dephosphorylation in wild-type Tetrahymena (Dou et al., 1999). In Tetrahymena strains in which the ®ve phosphorylation sites on macronuclear histone H1 were mutated to A (to prevent phosphorylation), H1 dephosphorylation accelerated transcriptional activation of CyP1. This eect was indistinguishable from that seen in mutants lacking H1, suggesting that transcriptional activation accompanies H1 depletion (Shen and Gorovsky, 1996) . On mononucleosomes assembled in vitro, addition of puri®ed histone H1 reduced the rate of BRG1 remodeling by approximately half (Hill and Imbalzano, 2000) . Two recent studies utilizing fusion proteins of GFP and H1 have monitored H1-chromatin interactions in living cells (Lever et al., 2000; Misteli et al., 2000) . They found that almost all cellular histone H1 is bound to chromatin at any one time, but that H1 rapidly exchanges between chromatin regions. In addition, dephosphorylation of H1 by the kinase inhibitor, staurosporine, rendered H1 less mobile raising the possibility that H1¯uidity may in¯uence chromatin remodeling.
The importance of histone H1 and its phosphorylation/dephosphorylation status in transcriptional regulation has also been demonstrated on the MMTV promoter. Glucocorticoid activation of MMTV transcription decreases the amount of promoter-associated histone H1 (Bresnick et al., 1992) . In addition, H1 phosphorylation status is intimately linked to the ability of the GR to transactivate the MMTV promoter (Lee and Archer, 1998) . (Figure 3a) . This association was discovered upon investigating the mechanisms by which prolonged hormone treatment leaves the MMTV promoter refractory to further GR activation. The promoter remains refractory despite the presence of required transcription factors in the nucleus, including the GR, which suggested that necessary factors were prevented from binding due to closing of nuc-B. To further investigate the mechanism of reduced transcriptional competency from the MMTV promoter, the phosphorylation state of histone H1 after short-term (1 h) and long-term (48 h) treatment of glucocorticoid was investigated. Prolonged exposure to hormone was accompanied by global dephosphorylation of histone H1, which correlated to the reduced transcriptional status of the promoter. Chromatin immunoprecipitation experiments con®rmed that phosphorylated H1 was replaced with dephosphorylated H1 under these conditions. Similarly, culturing cells in the presence of the kinase inhibitor staurosporine prevented the rephosphorylation of H1. As a result, GR mediated chromatin remodeling was blocked and the MMTV promoter remained transcriptionally inactive. This deactivation through H1 dephosphorylation was speci®c to the MMTV promoter, since after prolonged hormone exposure, neither the metallothionein gene nor the GAPDH gene showed the refractory period characteristic of MMTV. However, the promoter could be reactivated by the removal of hormone for a period greater than 24 h. This reactivation was accompanied by hormone-dependent hypersensitivity at the promoter and the binding of transcription factors as well as the rephosphorylation of histone H1. In contrast, if hormone was removed in the presence of the kinase inhibitor staurosporine, H1 was not rephosphorylated and the promoter remained refractory to hormone stimulation. The decreased activation of MMTV after prolonged hormone stimulation was unique to chromatin-assembled templates since a transiently introduced MMTV promoter was unaected. Indeed, these experiments provide further evidence for the concept that the GR possesses separable chromatin-related and transcription-related activities. Thus, the phosphorylation state of histone H1 on MMTV is intimately linked with transcriptional ability of the GR within chromatin, and suggests the novel possibility that this is achieved in part by the capacity of the GR to regulate the activity of a protein kinase responsible for H1 phosphorylation.
GR and other transcriptional coactivators
The GR activates and represses transcription on many promoters and in many cell types, and often requires other factors to confer transcriptional speci®city. The GR binds to coactivators such as p300/CBP, SRC1, TIF-2/GRIP-1, and ACTR/pCIP Windahl et al., 1999) . The variable composition of this GR-coactivator complex may allow¯exibility in transcriptional regulation of many promoters, including the MMTV promoter.
Several coactivators, such as p300/CBP and SRC1, have histone acetyltransferase activity (Robyr et al., 2000) . Both p300/CBP and SRC-1 have been shown to interact with the GR in a hormone-dependent manner . Acetylation of core histones regulates transcription of many promoters, including MMTV (Struhl, 1998) . Sodium butyrate, which induces histone hyperacetylation, inhibits glucocorticoid hormone-dependent nucleosome disruption and promoter activation from an MMTV template assembled as chromatin (Bresnick et al., 1990) . However, glucocorticoid activation from a transiently introduced MMTV template was unaected. In another study, sodium butyrate and a second deacetylase inhibitor, trichostatin A (TSA), activated transcription of the integrated MMTV promoter at low drug concentrations, but were inhibitory at higher concentrations that hyperacetylated the core histones (Bartsch et al., 1996) .
The dierential recruitment of coactivator complexes by the GR has also been investigated on the MMTV promoter. Activation of a stably integrated MMTV template by GR antagonists (antiglucocorticoids) was compared in human breast cancer cells and osteosarcoma cell lines . The antiglucocorticoid RU486, but not ZK98299, exhibited agonist activity in osteosarcoma but not breast cancer cells. As expected, RU486 remodeled chromatin and allowed transcription factor access to the MMTV promoter in osteosarcoma, but not breast cancer cells. When the mechanism of this activation was investigated, it was found that RU486 induced formation of a GR-BRG1 complex only in osteosarcoma cells. Interestingly these osteosarcoma and breast cancer cells diered in the expression pro®le for various components of the BRG1 complex. The most prominent of these dierences being the lack of BAF250, a component known to directly interact with the GR, in the breast cancer cells. In contrast, RU486 was unable to induce GR binding with SRC1, p300/CBP, or pCIP in either of the cell lines as would be predicted from previous interaction studies (Collingwood et al., 1999; Fryer et al., 2000; Nie et al., 2000) . The ability of the RU486-bound GR to bind BRG1 but not the coactivators parallels the weak agonist activity of RU486 compared to the glucocorticoid, dexamethasone. Thus, GR activation in diverse cell and tissues may be ®ne-tuned by regulating the composition of the GR-coactivator complex that can be assembled at a particular promoter.
Due to its ability to recruit dierent subsets of coactivators, the GR activates promoters assembled into both`open' and`closed' chromatin. In mouse cells where the MMTV promoter adopts a`closed' or repressed chromatin structure, GR binding the HREs is critical for chromatin remodeling and subsequent transcriptional activation. In human breast cancer cells containing the progesterone receptor (PR), the MMTV promoter integrates as an`open' and remodeled chromatin architecture . In this cell line, the transcription factor, NF-1, is bound to the promoter before and after hormone treatment. PR is also constitutively bound, but progestin treatment is required to activate MMTV transcription. When the antiprogestins ZK98299 and RU486 were used to investigate the mechanism of constitutive hypersensitivity in these cells, both antiprogestins blocked transcriptional activation by the synthetic progestin, R5020 . However the mechanisms by which the two antiprogestins inhibited transcription diered dramatically. ZK98299 treatment, which blocked the ability of the PR to bind chromatin, resulted in a`closed' chromatin structure and the eviction of bound transcription factors from the promoter. In contrast, the RU486-bound PR could bind DNA, as demonstrated by the maintenance of constitutive hypersensitivity, but it could not assemble the preinitiation complex required for transcription. Thus, as was demonstrated in osteosarcoma cells, nuclear receptors such as PR and GR can dierentially aect promoters depending on the characteristics of the speci®c ligand. In a second human breast cancer cell line containing the GR but not the PR, MMTV also adopts an`open' chromatin structure (Kinyamu et al., Figure 4 GR activation of the MMTV promoter on stable and transient templates. Please refer to text for model description 2000). Similarly, glucocorticoid treatment activated MMTV transcription. Speci®cally, the GR required the cofactor SRC1 for this activation. As we have shown, the integrated MMTV promoter can exist at various levels of`gene activation' as indicated by the extent of chromatin remodeling in the absence of hormone. The association of the GR with variable protein complexes may allow the GR to regulate hormone responsive promoters at various stages of activation. This¯exibility would be a great advantage for the GR considering the diverse range of natural promoters it can activate.
Conclusion
Studies using the MMTV promoter provide a relatively detailed picture of the events and molecules involved in the glucocorticoid-mediated activation of transcription within chromatin. (Figure 4 ). These include the identi®cation of characteristics of a transcriptionally competent promoter, determination of which cofactors are required for the activation of transcription and the mechanisms by which a promoter stops responding to a speci®c signal. In the absence of hormone, the promoter is assembled as a phased array of nucleosomes with phosphorylated histone H1 at the linker. Nuclear proteins such as NF1 and OTFs are competent to bind the promoter DNA but are blocked from doing so by the chromatin architecture of the promoter. The glucocorticoid receptor resides in the cytoplasm and various co-activators, including the BRG1 complex, p300/CBP and SRC1-3 are within the nucleus. Upon addition of hormone the GR translocates to the nucleus and associates with the BRG1 complex at least in part via a direct interaction with the BAF250 protein. At this point the promoter undergoes a series of discreet alterations, (1) the GR transiently interacts with the HREs; (2) this leads to the transient displacement of histone H1; (3) an alteration of the interaction of the DNA with the core histones such that the sequences become hypersensitive to cleavage by restriction enzymes, nucleases and chemical reagents; (4) the binding site for NF1 on nuc-B becomes available and is occupied by the NF1 protein; (5) the OTF proteins bind to the linker between nucleosomes A and B while the TBP protein binds to an unmodi®ed nucleosome A and transcription is initiated. When the cells are maintained in the presence of hormone for periods greater than 8 h the activation is reversed such that; (6) transcription initiation ceases, transcription factors are evicted from the promoter, the nuc-B architecture reverts to its pre-hormone state and is no longer hypersensitive; (7) histone H1 returns to the promoter but in a dephosphorylated state; and (8) the GR is retained in the nucleus but is either unable to deliver the remodeling complex to the promoter or the complex is unable to remodel the promoter when H1 is in a dephosphorylated state. (Figure 4) . If the hormone is removed for a similar period of time the GR is able to return to the cytoplasm, H1 is rephosphorylated with the reacquisition of transcriptional competence whereupon re-addition of hormone the activation cycle begins again. The fundamental role for chromatin structure is this activation cycle is illustrated by the mechanism of activation of the GR on a transiently introduced MMTV template such that; (3) the entire promoter is hypersensitive to cleavage agents; (4) NF1 and OTFs are bound prior to the addition of hormone; (6) upon prolonged hormone exposure transcription is maintained and transcription factors remain bound at the promoter; and (8) the chromatin remodeling complex is not required for transcription from the transiently transfected template. This picture, while detailed, is incomplete with respect to a number of speci®c issues. These include, but are not limited to, (i) what is the nature of the change in nuc-B DNA: histone contacts that render the region hypersensitive? (ii) What are the dierences in structure when the promoter is compacted with phosphorylated or dephosphorylated H1? (iii) Does H1 phosphorylation aect the ability of the GR to deliver the remodeling complex or the ability of the remodeling complex to alter the promoter chromatin? (iv) Can other remodeling complexes substitute for the BRG1 complex to activate transcription? and (v) Do coactivator complex acetyltransferase activities contribute to GR activation? The availability of improved in vitro reconstitution and transcription systems, puri®ed and cloned remodeling complexes, GFP-tagged receptors and co-activators and novel cell lines expressing varied remodeling complex components and co-activators will allow these and other questions to be explored.
